J.P. Morgan Private Wealth Advisors LLC - CRINETICS PHARMACEUTICALS IN ownership

CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 139 filers reported holding CRINETICS PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 19.18 and the average weighting 0.3%.

Quarter-by-quarter ownership
J.P. Morgan Private Wealth Advisors LLC ownership history of CRINETICS PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2023$348,759
+9.9%
19,354
-2.1%
0.00%
+100.0%
Q1 2023$317,362
-9.8%
19,761
+2.8%
0.00%0.0%
Q4 2022$351,65319,2160.00%
Other shareholders
CRINETICS PHARMACEUTICALS IN shareholders Q2 2023
NameSharesValueWeighting ↓
Vivo Capital, LLC 3,375,169$76,819,0007.66%
RA Capital Management 1,875,209$42,680,0001.84%
Perceptive Advisors 2,587,953$58,901,0001.66%
EMORY UNIVERSITY 97,035$2,209,0001.55%
New Leaf Venture Partners, L.L.C. 167,700$3,817,0001.05%
Orbimed Advisors 1,914,282$43,569,0000.67%
Opaleye Management Inc. 73,000$1,661,0000.46%
Novo Holdings A/S 135,009$3,073,0000.46%
Virtus ETF Advisers LLC 7,934$181,0000.38%
Eventide Asset Management 384,000$8,740,0000.30%
View complete list of CRINETICS PHARMACEUTICALS IN shareholders